Results 151 to 160 of about 3,238 (172)

The use of sequence analysis of a feline calicivirus (FCV) hypervariable region in the epidemiological investigation of FCV related disease and vaccine failures

Vaccine, 1997
A reverse transcriptase polymerase chain reaction (PCR) was used to amplify a 235 bp hypervariable region of the feline calicivirus (FCV) genome which encodes part of the capsid protein. Sequence from this region was used to compare viruses used in three attenuated vaccines to viruses isolated from vaccinated cats with clinical signs of FCV-infection ...
Alan Radford, Malcolm Bennett, F. McArdle, Susan Dawson, Philip Turner, Mark Glenn, Rosalind M. Gaskell   +6 more
openalex   +3 more sources

Capsid Protein Genetic Analysis and Viral Spread to the Spinal Cord in Cats Experimentally Infected with Feline Calicivirus (FCV)

Veterinary Research Communications, 2005
We investigated primitively the molecular basis of the neural spread of a feline calcivirus isolate (FCV-S) from the spinal cord of a cat that died after manifesting excitation. Experimental infections of cats with three clones from parent virus isolate FCV-S, isolated based on plaque size, were performed, and virus recovery from the spinal cord and ...
Yukihiro Fujita, Y. Sato, K. Ohe, S. Sakai, Masahiro Fukuyama, Katsunori Furuhata, Seigo Kishikawa, Shota Yamamoto, Akio Kiuchi, M Hara, Yoshihiro Ishikawa, Akira Taneno   +11 more
openalex   +3 more sources

Detection of Feline calicivirus (FCV) from Vaccinated Cats and Phylogenetic Analysis of its Capsid Genes

Veterinary Research Communications, 2006
We analysed genogroups of four feline calcivirus (FCV) isolates (FCV-S, H10, Ao198-1 and ML89) obtained from cats that experienced FCV infection after having been vaccinated against FCV. New PCR primer sets (8F/8R, Ao-S/Ao-A, cp-S/cp-A) were also designed, since the conventional Seal primer failed to amplify the target sequences in two samples.
K. Ohe, S. Sakai, Fujiko Sunaga, Masaru Murakami, Akio Kiuchi, Masahiro Fukuyama, Katsunori Furuhata, M Hara, Takehisa SOMA, Yoshihiro Ishikawa, Akira Taneno   +10 more
openalex   +3 more sources

Efficacy of an inactivated feline calicivirus (FCV) vaccine against challenge with United Kingdom field strains and its interaction with the FCV carrier state

Research in Veterinary Science, 1982
The efficacy of an inactivated vaccine derived from feline calicivirus (FCV) strain FS2 was assessed against challenge with three UK field strains of FCV. The mean clinical score, calculated on the number of signs recorded per day over 21 days after challenge, was lower for vaccinated cats when compared to unvaccinated animals though the difference was
C. J. Gaskell, Rosalind M. Gaskell, Patrick Dennis, M. Wooldridge   +3 more
openalex   +3 more sources

In vitro inactivation of feline calicivirus (FCV) by chemical disinfectants: resistance variation among field strains

Archives of Virology, 2010
Several commercial products commonly used for disinfection against feline calicivirus (FCV) have been validated using the vaccine strain F9. However, little information is available regarding the resistance of field strains of FCV to chemical inactivation.
Barbara Di Martino, Chiara Ceci, Federica Di Profio, Fulvio Marsilio   +3 more
openalex   +3 more sources

Potential for broad-spectrum protection against feline calicivirus using an attenuated myxoma virus expressing a chimeric FCV capsid protein

Vaccine, 2005
It has previously been demonstrated that recombinant myxoma viruses expressing FCV capsid protein are capable of eliciting protective responses against virulent FCV challenge, following vaccination, in cats. An attempt was made to produce a bivalent myxoma recombinant expressing the capsid protein genes of both FCV strains F9 and LS015.
Victoria J. McCabe, N. Spibey
openalex   +3 more sources

Molecular epidemiology of feline calicivirus (FCV) and felid alphaherpesvirus 1 (FeAHV-1) in cats with clinical signs and clinically healthy cats

Comparative Immunology, Microbiology and Infectious Diseases
Feline Calicivirus (FCV) and Felid Alphaherpesvirus 1 (FeAHV-1), commonly detected in cats, are significant viral pathogens causing upper respiratory tract disease (URTD) and various clinical signs. Co-infection with both viruses is common and a major problem in feline health worldwide.
Gülizar Acar, Seval Bilge Dağalp, Tarık Fedai, Mehmet Özkan Timurkan, Hakan Aydın   +4 more
openalex   +3 more sources

Temperature inactivation of Feline calicivirus vaccine strain FCV F-9 in comparison with human noroviruses using an RNA exposure assay and reverse transcribed quantitative real-time polymerase chain reaction—A novel method for predicting virus infectivity

Journal of Virological Methods, 2008
A one-step reverse transcription quantitative real-time polymerase chain reaction (RT-QPCR) method in combination with RNase treatment and low copy number samples was developed in order to examine the effect of temperature on the ability of virus capsids to protect their RNA content.
Joanna Topping, Helge Schnerr, John Haines, Mary T. Scott, M J Carter, M. M. Willcocks, K. Bellamy, David Brown, James J. Gray, Chris I. Gallimore, A.I. Knight   +10 more
openalex   +4 more sources

Transcriptome analysis of Crandell Rees Feline Kidney (CRFK) cells infected with Feline calicivirus strain 023 (FCV 023)

Virology
R. Zhang, Hongwei Zhu, Guangrong Zhao, Xiu Xue, Xin Yu, Yang Liu, Jiayu Yu, Linlin Jiang, Jianlong Zhang, Xingxiao Zhang   +9 more
openalex   +2 more sources

[Yearly booster vaccine against feline calicivirus (FCV) for high risk cases].

Tijdschrift voor diergeneeskunde, 2007

openalex   +2 more sources